Noradrenergic and dopaminergic interrelation in schizophrenia.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Psychiatry Research

• Publication date

  1994-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0165-1781(94)90052-3PMID 7870845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biogenic amine metabolites in plasma of drug-naive schizophrenic patients: associations with symptomatology.

  1992cited by this paper
• Plasma free 3-methoxy-4-hydroxyphenylglycol in acute schizophrenics before and after treatment.

  1992cited by this paper
• Plasma homovanillic acid, plasma anti-D1 and -D2 dopamine-receptor activity, and negative symptoms in chronically mediated schizophrenia.

  1992cited by this paper
• Dopamine in schizophrenia: a review and reconceptualization.

  1991cited by this paper
• Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.

  1991cited by this paper
• Plasma norepinephrine in chronic schizophrenia.

  1990cited by this paper
• Evidence for reduced and dysregulated turnover of dopamine in schizophrenia.

  1990cited by this paper
• Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.

  1990cited by this paper
• Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

  1990cited by this paper
• Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.

  1990cited by this paper
• Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

  1990cited by this paper
• CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.

  1989cited by this paper
• The current status of the dopamine hypothesis of schizophrenia.

  1988cited by this paper
• Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtype.

  1988cited by this paper
• Alpha-adrenoceptor function in acute paranoid schizophrenia.

  1988cited by this paper
• Characteristics of patients with the highest plasma catecholamine metabolite levels.

  1988cited by this paper
• A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.

  1988cited by this paper
• Neuroendocrine findings in the schizophrenias.

  1988cited by this paper
• Dopamine as a mediator of a central stabilizing system.

  1988cited by this paper
• Dopamine receptor subtype imbalance in schizophrenia.

  1987cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Dopamine receptors and the dopamine hypothesis of schizophrenia

  1987cited by this paper
• The dopamine hypothesis: variations on a theme (II).

  1986cited by this paper
• Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history.

  1985cited by this paper
• Overview: toward a dysregulation hypothesis of depression.

  1985cited by this paper
• The Dopamine Hypothesis: Variations on a Theme

  1985cited by this paper
• Are there state-dependent markers in schizophrenia?

  1985cited by this paper
• The two-syndrome concept: origins and current status.

  1985cited by this paper
• Impaired noradrenergic transmission in schizophrenia?

  1984cited by this paper
• Plasma catecholamine metabolites and early response to haloperidol.

  1984cited by this paper
• Catecholamines and their receptors in blood: evidence for alterations in schizophrenia.

  1984cited by this paper
• Clonidine‐induced growth hormone secretion in chronic schizophrenia

  1983cited by this paper
• Growth hormone responses to graded doses of apomorphine HCl in schizophrenia.

  1983cited by this paper
• Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients.

  1983cited by this paper
• Brain catecholamines in schizophrenia — a good case for noradrenaline

  1982cited by this paper
• Increased noradrenaline levels in CSF and plasma of schizophrenic patients.

  1982cited by this paper
• Impaired presynaptic regulation of norepinephrine in schizophrenia. Effects of clonidine in schizophrenic patients and normal controls.

  1982cited by this paper
• Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion.

  1982cited by this paper
• Hormones, dopamine receptors and schizophrenia.

  1981cited by this paper
• Schizophrenia: elevated cerebrospinal fluid norepinephrine.

  1980cited by this paper
• Molecular pathology of schizophrenia: more than one disease process?

  1980cited by this paper
• Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

  1979cited by this paper
• Neuroendocrine studies with dopamine agonists in schizophrenia.

  1978cited by this paper
• Postsynaptic supersensitivity in schizophrenia.

  1977cited by this paper
• Dopamine receptor alteration in schizophrenia: Neuroendocrine evidence

  1976cited by this paper
• Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

  1971cited by this paper
• The Brief Psychiatric Rating Scale

  1962cited by this paper

• Systematic Review of the Apomorphine Challenge Test in the Assessment of Dopaminergic Activity in Schizophrenia

  2023cites this paper
• Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders

  2020cites this paper
• Is elevated norepinephrine an etiological factor in some cases of schizophrenia?

  2014cites this paper
• Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia

  2002cites this paper
• Different neuroendocrine profiles of remitted and nonremitted schizophrenic patients.

  2002cites this paper
• Anterior Cingulate Metabolism Correlates with Stroop Errors in Paranoid Schizophrenia Patients

  2001cites this paper
• Multihormonal responses to clonidine in patients with affective and psychotic symptoms.

  2000cites this paper
• Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia.

  1998cites this paper
• Psychoneuroendocrinology of schizophrenia.

  1998cites this paper
• Current awareness in human psychopharmacology

  1995cites this paper